← All stocks

Alamar Biosciences, Inc.

ALMR Net buying

CIK 0002104204 #1915 in the set updated 17 Sep 2026

Bought (12 mo)

$8.00M

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

+$8.00M

+$8.00M against sales at will

By person

9 insiders · 2 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Illumina Innovation Fund II GP, L.L.C. entity

10% owner

$4.00M (1)

—

+$4.00M

507,076

$8.62M

—

Naclerio Nicholas

Director

$4.00M (1)

—

+$4.00M

512,762

$8.72M

—

Luo Yuling

Chief Executive Officer

—

3,164,726

$53.80M

+2,699%

Qiming Corporate GP VI, Ltd. entity

10% owner

—

1,922,329

$32.68M

—

Chen Shiping

Chief Operating Officer

—

760,105

$12.92M

+130.7%

White Timothy Ogden

President

—

491,803

$8.36M

+8.2%

McAnear Justin J.

Chief Financial Officer

—

37,220

$632.74K

—

Brottem John L.

General Counsel

—

29,000

$493.00K

—

RAGUSA ROBERT P

Director

—

5,686

$96.66K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Naclerio Nicholas

20 Apr 2026

Director

Buy indirect

235,294

$17.00

$4.00M

Illumina Innovation Fund II GP, L.L.C.

20 Apr 2026

10% owner

Buy indirect

235,294

$17.00

$4.00M

What was left out

Form 4 filings counted 11

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 2

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 78,210,782

History held since 20 Apr 2026